As AI-powered wearables gain popularity, neurologists explain what these devices can truly measure, why they cannot diagnose ...

Beyond smart watches and rings, artificial intelligence is being used to make self-testing for major diseases more readily available -- from headsets that detect early signs of Alzheimer's to an ...

The randomized, double-blind, sham-controlled trial evaluated 56 adults with ADHD who received four weeks of Nexalin’s ...

Alto Neuroscience, Inc. ("Alto") (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced ...

The Swoop portable MRI system showed 92% agreement with traditional MRI scans and was four times more likely to be chosen by ...

A man with long-standing exploding head syndrome and sleep paralysis reports fewer and less intense episodes after low-dose ...

Results from the NEURO PMR study, presented by Dr. Laszlo Mechtler at the ASN Annual Meeting in San Juan, Puerto Rico, on January 16, 2026.

Baseline theta oscillations may serve as a risk biomarker for psychosis in patients that are at clinical high risk.

Staying sharp on the stick.

Sleep technology is moving beyond tracking, as device makers and health groups focus on shaping sleep, writes ARTHUR GOLDSTUCK.

Researchers at the University of New South Wales Sydney are testing a new way to treat chronic nerve pain by training the brain itself. The approach relies on an interactive game that teaches people ...